NCT01988168

Brief Summary

The purpose of the CSCAR pilot study is to improve the design of a full-scale trial by determining the patient recruitment rate and participation rate. The objective of the full-scale trial is to determine the optimal method of skin closure after Caesarean delivery in women with chorioamnionitis, which is an acute inflammation of the membranes and chorion of the placenta, seen typically after rupture of membranes with ascending polymicrobial bacterial infection. Women in labour with chorioamnionitis will be randomized at the time of Caesarean delivery to skin closure with either staples or sutures. The women will be followed at 6 weeks and 6 months post-partum in order to establish the occurrence of surgical site infection and wound disruption, as well as evaluation of the scar and other secondary questions. The investigators hypothesis is that closure of skin with sutures will have a rate of wound infection that is no higher than the rate of wound infection when closing skin with staples. The investigators also hypothesize that closure with sutures will have a decreased rate of wound disruption, increased patient satisfaction and decreased length of hospital stay compared to skin closure with staples.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2013

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 20, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

May 12, 2017

Status Verified

May 1, 2017

Enrollment Period

5.8 years

First QC Date

October 31, 2013

Last Update Submit

May 11, 2017

Conditions

Keywords

Suture TechniquesSuturesSurgical Staplers

Outcome Measures

Primary Outcomes (1)

  • Patient recruitment rate

    The patient recruitment rate will be calculated as the total number of women successfully recruited to the trial divided by the total duration of the trial.

    1 year

Secondary Outcomes (6)

  • Follow-up rates

    6 months post-operative

  • Wound infection

    6 months post-operative

  • Wound disruption

    6 months post-operative

  • Wound cosmesis

    6 months post-operative

  • Patient satisfaction

    6 months post-operative

  • +1 more secondary outcomes

Study Arms (2)

Suture closure

EXPERIMENTAL

Closure of skin with a running subcuticular, absorbable monofilament suture.

Procedure: Suture closure

Staples closure

ACTIVE COMPARATOR

Closure of skin with stainless-steel surgical staples.

Procedure: Staples closure

Interventions

A running subcuticular suture is placed by taking horizontal bites through the papillary dermis on alternating sides of the wound. An absorbable suture is used and left in place until degraded and absorbed by the patient's tissues.

Also known as: 3-0 Monocryl suture (from Ethicon)
Suture closure

Surgical stapling devices re-appose skin edges with stainless steel or titanium staples. A second operator everts the wound skin edges while the operator applies staples along the incision. Staples can be removed on post-operative day 2 or 3, or delayed further according the surgeon preference based on patient characteristics.

Staples closure

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of chorioamnionitis (Fever ≥ 38.0°C AND at least TWO of: Maternal tachycardia: Heart rate \> 100bpm, Fetal tachycardia: Baseline heart rate \> 160bpm, Uterine tenderness, Foul smelling / purulent vaginal discharge, White Blood Cell count \> 15,000 cells/mm3)
  • Caesarean delivery with Pfannenstiel incision
  • Pregnancies \>24 weeks
  • Scheduled or non-elective procedures
  • Primary or repeat Caesarean delivery
  • No restrictions based on BMI

You may not qualify if:

  • Non-Pfannenstiel incision
  • Immune compromising disease
  • History of keloid formation
  • Chronic steroid use
  • Allergy to staples
  • Planned postpartum care at another facility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's and Women's Health Centre of British Columbia

Vancouver, British Columbia, V6H 3N1, Canada

RECRUITING

MeSH Terms

Conditions

ChorioamnionitisPregnancy Complications, InfectiousPostoperative Complications

Interventions

Sutures

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesFetal Membranes, Premature RuptureObstetric Labor ComplicationsPlacenta DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfectionsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Surgical Fixation DevicesSurgical EquipmentEquipment and Supplies

Study Officials

  • Ellen M Giesbrecht, MD

    Clinical Assistant Professor, Division of General Gynaecology & Obstetrics, Department of Obstetrics and Gynaecology, University of British Columbia; Site Head, Department of Obstetrics, BC Women's Hospital

    PRINCIPAL INVESTIGATOR
  • Jennifer A Hutcheon, PhD

    Assistant Professor, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynaecology, University of British Columbia

    STUDY DIRECTOR
  • Julie E van Schalkwyk, MD

    Clinical Assistant Professor, Division of General Gynaecology & Obstetrics, Department of Obstetrics and Gynaecology, University of British Columbia

    STUDY DIRECTOR
  • Michael WH Suen, MD

    Resident, Department of Obstetrics and Gynaecology, University of British Columbia

    STUDY DIRECTOR

Central Study Contacts

Ellen M Giesbrecht, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

October 31, 2013

First Posted

November 20, 2013

Study Start

February 1, 2014

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

May 12, 2017

Record last verified: 2017-05

Locations